Mer­ck makes first big splash for Alzheimer’s drug R&D since 2017 fail, ink­ing re­search pact with Cere­vance

For the first time since dis­con­tin­u­ing its late-stage Alzheimer’s pro­gram, Mer­ck has found promise on the path for­ward in the mem­o­ry-rob­bing dis­ease.

Af­ter a Phase …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER